Sangamo Therapeutics Inc Capital Reinvestment Ratio
Sangamo Therapeutics Inc capital reinvestment ratio. Sangamo Therapeutics Inc (SGMO) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow ($11.76 Million) in capital expenditures ($115.00K). Check SGMO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sangamo Therapeutics Inc (2017–2020)
Capital reinvestment ratio of Sangamo Therapeutics Inc from 2017 to 2020. This chart tracks Sangamo Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Sangamo Therapeutics Inc (SGMO) net asset momentum to track the company's year-over-year net asset growth rate.
Sangamo Therapeutics Inc Capital Reinvestment Ratio by Year (2017–2020)
Sangamo Therapeutics Inc capital reinvestment ratio by year from 2017 to 2020. For the full cash flow conversion analysis, see Sangamo Therapeutics Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.09x | $169.88 Million | $14.71 Million | ▼ -92.5% |
| 2018 | 1.16x | $37.15 Million | $43.06 Million | ▲ +245.5% |
| 2017 | 0.34x | $11.18 Million | $3.75 Million | — |